JPRN-UMIN000001266未知3 期
Therapeutic efficacy of ezetimibe for use minute lipid analyzer: LipoSEARCH in patients with nonalcoholic steatohepatitis (NASH) complicated with hyperlipidemia: a pilot study. - Efficacy of ezetimibe in NASH patients
Division of Gastroenterology, Yokohama City University Hospital0 个研究点目标入组 10 人开始时间: 2008年7月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a.The criteria for exclusion from participation in the study: history of hepatic disease, such as chronic hepatitis C or concurrent active hepatitis B (serum positive for hepatitis B surface antigen), autoimmune hepatitis, primary biliary cirrhosis (PBC), sclerosing cholangitis, hemochromatosis, alpha1-antitrypsin deficiency, Wilsons disease, and current or past consumption of more than 20 g of alcohol daily. b. None of the patients had any clinical evidence of hepatic decompensation, such as hepatic encephalopathy, ascites, variceal bleeding, or elevated serum bilirubin level to more than twofold the upper limit of normal.
研究者
相似试验
已完成
不适用
Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.Dyslipidemia complicated insulin resistanceJPRN-UMIN000005775The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital47
进行中（未招募）
1 期
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyAdolescent (age >=10 and <=17 years) subjects with Heterozygous Familial Hypercholesterolemia (HeFH).MedDRA version: 7.0 Level: LLT Classification code 10057099EUCTR2004-002627-40-ESSchering-Plough Research Institute248
进行中（未招募）
不适用
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyAdolescent (age >=10 and <=17 years) subjects with Heterozygous Familial Hypercholesterolemia (HeFH).MedDRA version: 7.0Level: LLTClassification code 10057099EUCTR2004-002627-40-ATSchering-Plough Research Institute210
进行中（未招募）
不适用
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyEUCTR2004-002627-40-DESchering-Plough Research Institute on behalf of MSP Singapore Company, LLC210
进行中（未招募）
1 期
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyEUCTR2004-002627-40-FISchering-Plough Research Institute248